NCT07168629 A Community Health Intervention to Improve Lung Cancer Screening Uptake in Community Health Centers
| NCT ID | NCT07168629 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Baystate Medical Center |
| Condition | Lung Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2026-05-10 |
| Primary Completion | 2028-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2026-05-10 with a primary completion date of 2028-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Lung cancer screening (LCS) can reduce lung cancer-related mortality, but screening uptake remains low among eligible individuals. The goal of this study is to partner with community stakeholders to develop and pilot test a multi-component navigator-delivered intervention targeting key barriers to lung cancer screening and tobacco treatment utilization. Participants are randomized to enhanced usual care, a community health worker (CHW)-delivered intervention, or the same intervention delivered by a trained lay navigator. The intervention includes patient outreach, patient-centered shared decision-making, tobacco treatment counseling, and assistance navigating logistical barriers to care. The proposed activities will lay the groundwork for a subsequent fully powered randomized clinical trial evaluating CHW- and lay navigator-delivered approaches to facilitate access to lung cancer screening and tobacco treatment.
Eligibility Criteria
Inclusion Criteria: * Adults between the age of 50 and 80. * Potentially eligible for LCS according to the Electronic Health Record smoking history. * Receive their primary care at Mason Square, High Street, or Brightwood community health centers. * English- or Spanish- speaking. Exclusion Criteria: * Not eligible for lung cancer screening based on age (age \< 50 or \> 80 years) or smoking history (has not smoked more than 20 pack-years of tobacco cigarettes or quit more than 15 years ago). * Have received a lung cancer screen in the past.
Contact & Investigator
Jennifer Pacheco
STUDY DIRECTOR
Baystate Health
Frequently Asked Questions
Who can join the NCT07168629 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 80 Years, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07168629 currently recruiting?
Yes, NCT07168629 is actively recruiting participants. Contact the research team at Eduardo.nunez2@baystatehealth.org for enrollment information.
Where is the NCT07168629 trial being conducted?
This trial is being conducted at Springfield, United States.
Who is sponsoring the NCT07168629 clinical trial?
NCT07168629 is sponsored by Baystate Medical Center. The principal investigator is Jennifer Pacheco at Baystate Health. The trial plans to enroll 120 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.